Craft

Advanced
  • Home
  •  / Forte Biosciences
Forte Biosciences

Forte Biosciences

Stock Price

$4.6

2024-10-29

Market Capitalization

$6.7 M

2024-10-29

Revenue

$36 K

FY, 2019

Forte Biosciences Summary

Company Summary

Overview
Forte Biosciences (formerly known as Tocagen) is a biopharmaceutical company focused on dermatology. Its lead product, FB-401, is a live biotherapeutic for the treatment of inflammatory skin disease.
Type
Public
Status
Active
Founded
2001
HQ
Torrance, CA, US | view all locations
Website
https://www.fortebiorx.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Table of Contents

Key People

  • Mark G. Foletta

    Mark G. Foletta, Executive Vice President and Chief Financial Officer

  • Douglas J. Jolly

    Douglas J. Jolly, Executive Vice President, Research and Pharmaceutical Development

  • Harry E. Gruber

    Harry E. Gruber, President, Science and Innovation, Director

    • John F. Wood

      John F. Wood, Senior Vice President, Regulatory Affairs and Quality Assurance

    LocationsView all

    2 locations detected

    • Torrance, CA HQ

      United States

      1124 W Carson St building 3

    • San Diego, CA

      United States

      4242 Campus Point Ct #600

    Forte Biosciences Financials

    Summary Financials

    Net income (Q1, 2026)
    ($22.1M)
    Cash (Q1, 2026)
    $58.2M
    EBIT (Q1, 2026)
    ($22.4M)

    Competitors and Similar Companies

    Compare competitors

    Footer menu

    Product

    Solutions

    Resources

    Company

    © Craft.co 2026
    Share price data provided by IEX